Entering text into the input field will update the search result below

Pluristem +5% on collaborating with NASA to study PLX therapeutic benefits in space missions

Feb. 20, 2019 8:57 AM ETPluri Inc. (PLUR) StockBy: SA News Team
  • Pluristem Therapeutics (NASDAQ:PSTI) collaborates with NASA’s Ames Research Center to evaluate the potential of Pluristem’s PLX cell therapies in preventing and treating medical conditions caused during space missions.
  • The project, titled, “Therapeutic Stromal Cells for Health in Space,” has been selected to prevent and treat medical conditions relating to blood, bone, muscle, brain and heart.
  • Shares are up 5% premarket.

Recommended For You

More Trending News

About PLUR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PLUR--
Pluri Inc.